Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The prostate is a walnut-sized gland located behind the base of a man’s penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.
The classification of Prostate Cancer Diagnostics includes Tumor Biomarker Tests, Imaging, Biopsy and other, and most of Prostate Cancer Diagnostics use the method of Biopsy, the proportion of Biopsy in 2017 is about 44.65%.Prostate Cancer Diagnostics is widely used for the people with Prostate Cancer, The most proportion of Prostate Cancer Diagnostics is used for people with the age between 55 and 75, and the proportion is about 70.24% in 2017.North America region is the largest region of Prostate Cancer Diagnostics, with a revenue market share nearly 49.84% in 2017. Europe is the second region of Prostate Cancer Diagnostics, enjoying revenue market share nearly 28% in 2017.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Prostate Cancer Diagnostics market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Prostate Cancer Diagnostics market. Detailed analysis of key players, along with key growth strategies adopted by Prostate Cancer Diagnostics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
BioMeriux
MDx Health
Siemens Healthcare
OPKO
Genomic Health
Roche
Ambry Genetics
Abbott
Myriad Genetics
Beckman Coulter
DiaSorin
By Type:
Tumor Biomarker Tests
Imaging
Biopsy
Other
By End-User:
age < 55
age 55-75
age > 75
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Prostate Cancer Diagnostics Market
-
1.3 Market Segment by Type
-
1.3.1 USA Prostate Cancer Diagnostics Market Size and Growth Rate of Tumor Biomarker Tests from 2016 to 2027
-
1.3.2 USA Prostate Cancer Diagnostics Market Size and Growth Rate of Imaging from 2016 to 2027
-
1.3.3 USA Prostate Cancer Diagnostics Market Size and Growth Rate of Biopsy from 2016 to 2027
-
1.3.4 USA Prostate Cancer Diagnostics Market Size and Growth Rate of Other from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Prostate Cancer Diagnostics Market Size and Growth Rate of age < 55 from 2016 to 2027
-
1.4.2 USA Prostate Cancer Diagnostics Market Size and Growth Rate of age 55-75 from 2016 to 2027
-
1.4.3 USA Prostate Cancer Diagnostics Market Size and Growth Rate of age > 75 from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Prostate Cancer Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Prostate Cancer Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Prostate Cancer Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Prostate Cancer Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Prostate Cancer Diagnostics Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Prostate Cancer Diagnostics by Major Types
-
3.4.1 Market Size and Growth Rate of Tumor Biomarker Tests
-
3.4.2 Market Size and Growth Rate of Imaging
-
3.4.3 Market Size and Growth Rate of Biopsy
-
3.4.4 Market Size and Growth Rate of Other
4 Segmentation of Prostate Cancer Diagnostics Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Prostate Cancer Diagnostics by Major End-Users
-
4.4.1 Market Size and Growth Rate of Prostate Cancer Diagnostics in age < 55
-
4.4.2 Market Size and Growth Rate of Prostate Cancer Diagnostics in age 55-75
-
4.4.3 Market Size and Growth Rate of Prostate Cancer Diagnostics in age > 75
5 Market Analysis by Regions
-
5.1 USA Prostate Cancer Diagnostics Production Analysis by Regions
-
5.2 USA Prostate Cancer Diagnostics Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Prostate Cancer Diagnostics Landscape Analysis
-
6.1 West USA Prostate Cancer Diagnostics Landscape Analysis by Major Types
-
6.2 West USA Prostate Cancer Diagnostics Landscape Analysis by Major End-Users
7 South USA Prostate Cancer Diagnostics Landscape Analysis
-
7.1 South USA Prostate Cancer Diagnostics Landscape Analysis by Major Types
-
7.2 South USA Prostate Cancer Diagnostics Landscape Analysis by Major End-Users
8 Middle West USA Prostate Cancer Diagnostics Landscape Analysis
-
8.1 Middle West USA Prostate Cancer Diagnostics Landscape Analysis by Major Types
-
8.2 Middle West USA Prostate Cancer Diagnostics Landscape Analysis by Major End-Users
9 Northeast USA Prostate Cancer Diagnostics Landscape Analysis
-
9.1 Northeast USA Prostate Cancer Diagnostics Landscape Analysis by Major Types
-
9.2 Northeast USA Prostate Cancer Diagnostics Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 BioMeriux
-
10.1.1 BioMeriux Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 MDx Health
-
10.2.1 MDx Health Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Siemens Healthcare
-
10.3.1 Siemens Healthcare Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 OPKO
-
10.4.1 OPKO Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Genomic Health
-
10.5.1 Genomic Health Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Roche
-
10.6.1 Roche Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Ambry Genetics
-
10.7.1 Ambry Genetics Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Abbott
-
10.8.1 Abbott Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Myriad Genetics
-
10.9.1 Myriad Genetics Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 Beckman Coulter
-
10.10.1 Beckman Coulter Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
-
10.11 DiaSorin
-
10.11.1 DiaSorin Company Profile and Recent Development
-
10.11.2 Market Performance
-
10.11.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Prostate Cancer Diagnostics Market Size and Growth Rate of Tumor Biomarker Tests from 2016 to 2027
-
Figure USA Prostate Cancer Diagnostics Market Size and Growth Rate of Imaging from 2016 to 2027
-
Figure USA Prostate Cancer Diagnostics Market Size and Growth Rate of Biopsy from 2016 to 2027
-
Figure USA Prostate Cancer Diagnostics Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Prostate Cancer Diagnostics Market Size and Growth Rate of age < 55 from 2016 to 2027
-
Figure USA Prostate Cancer Diagnostics Market Size and Growth Rate of age 55-75 from 2016 to 2027
-
Figure USA Prostate Cancer Diagnostics Market Size and Growth Rate of age > 75 from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Prostate Cancer Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Prostate Cancer Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Prostate Cancer Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Prostate Cancer Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Prostate Cancer Diagnostics Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Prostate Cancer Diagnostics
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Prostate Cancer Diagnostics by Different Types from 2016 to 2027
-
Table Consumption Share of Prostate Cancer Diagnostics by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Tumor Biomarker Tests
-
Figure Market Size and Growth Rate of Imaging
-
Figure Market Size and Growth Rate of Biopsy
-
Figure Market Size and Growth Rate of Other
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Prostate Cancer Diagnostics by Different End-Users from 2016 to 2027
-
Table Consumption Share of Prostate Cancer Diagnostics by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of age < 55
-
Figure Market Size and Growth Rate of age 55-75
-
Figure Market Size and Growth Rate of age > 75
-
Table USA Prostate Cancer Diagnostics Production by Regions
-
Table USA Prostate Cancer Diagnostics Production Share by Regions
-
Figure USA Prostate Cancer Diagnostics Production Share by Regions in 2016
-
Figure USA Prostate Cancer Diagnostics Production Share by Regions in 2021
-
Figure USA Prostate Cancer Diagnostics Production Share by Regions in 2027
-
Table USA Prostate Cancer Diagnostics Consumption by Regions
-
Table USA Prostate Cancer Diagnostics Consumption Share by Regions
-
Figure USA Prostate Cancer Diagnostics Consumption Share by Regions in 2016
-
Figure USA Prostate Cancer Diagnostics Consumption Share by Regions in 2021
-
Figure USA Prostate Cancer Diagnostics Consumption Share by Regions in 2027
-
Table West USA Prostate Cancer Diagnostics Consumption by Types from 2016 to 2027
-
Table West USA Prostate Cancer Diagnostics Consumption Share by Types from 2016 to 2027
-
Figure West USA Prostate Cancer Diagnostics Consumption Share by Types in 2016
-
Figure West USA Prostate Cancer Diagnostics Consumption Share by Types in 2021
-
Figure West USA Prostate Cancer Diagnostics Consumption Share by Types in 2027
-
Table West USA Prostate Cancer Diagnostics Consumption by End-Users from 2016 to 2027
-
Table West USA Prostate Cancer Diagnostics Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Prostate Cancer Diagnostics Consumption Share by End-Users in 2016
-
Figure West USA Prostate Cancer Diagnostics Consumption Share by End-Users in 2021
-
Figure West USA Prostate Cancer Diagnostics Consumption Share by End-Users in 2027
-
Table South USA Prostate Cancer Diagnostics Consumption by Types from 2016 to 2027
-
Table South USA Prostate Cancer Diagnostics Consumption Share by Types from 2016 to 2027
-
Figure South USA Prostate Cancer Diagnostics Consumption Share by Types in 2016
-
Figure South USA Prostate Cancer Diagnostics Consumption Share by Types in 2021
-
Figure South USA Prostate Cancer Diagnostics Consumption Share by Types in 2027
-
Table South USA Prostate Cancer Diagnostics Consumption by End-Users from 2016 to 2027
-
Table South USA Prostate Cancer Diagnostics Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Prostate Cancer Diagnostics Consumption Share by End-Users in 2016
-
Figure South USA Prostate Cancer Diagnostics Consumption Share by End-Users in 2021
-
Figure South USA Prostate Cancer Diagnostics Consumption Share by End-Users in 2027
-
Table Middle West USA Prostate Cancer Diagnostics Consumption by Types from 2016 to 2027
-
Table Middle West USA Prostate Cancer Diagnostics Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Prostate Cancer Diagnostics Consumption Share by Types in 2016
-
Figure Middle West USA Prostate Cancer Diagnostics Consumption Share by Types in 2021
-
Figure Middle West USA Prostate Cancer Diagnostics Consumption Share by Types in 2027
-
Table Middle West USA Prostate Cancer Diagnostics Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Prostate Cancer Diagnostics Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Prostate Cancer Diagnostics Consumption Share by End-Users in 2016
-
Figure Middle West USA Prostate Cancer Diagnostics Consumption Share by End-Users in 2021
-
Figure Middle West USA Prostate Cancer Diagnostics Consumption Share by End-Users in 2027
-
Table Northeast USA Prostate Cancer Diagnostics Consumption by Types from 2016 to 2027
-
Table Northeast USA Prostate Cancer Diagnostics Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Prostate Cancer Diagnostics Consumption Share by Types in 2016
-
Figure Northeast USA Prostate Cancer Diagnostics Consumption Share by Types in 2021
-
Figure Northeast USA Prostate Cancer Diagnostics Consumption Share by Types in 2027
-
Table Northeast USA Prostate Cancer Diagnostics Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Prostate Cancer Diagnostics Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Prostate Cancer Diagnostics Consumption Share by End-Users in 2016
-
Figure Northeast USA Prostate Cancer Diagnostics Consumption Share by End-Users in 2021
-
Figure Northeast USA Prostate Cancer Diagnostics Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of BioMeriux
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioMeriux
-
Figure Sales and Growth Rate Analysis of BioMeriux
-
Figure Revenue and Market Share Analysis of BioMeriux
-
Table Product and Service Introduction of BioMeriux
-
Table Company Profile and Development Status of MDx Health
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of MDx Health
-
Figure Sales and Growth Rate Analysis of MDx Health
-
Figure Revenue and Market Share Analysis of MDx Health
-
Table Product and Service Introduction of MDx Health
-
Table Company Profile and Development Status of Siemens Healthcare
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Siemens Healthcare
-
Figure Sales and Growth Rate Analysis of Siemens Healthcare
-
Figure Revenue and Market Share Analysis of Siemens Healthcare
-
Table Product and Service Introduction of Siemens Healthcare
-
Table Company Profile and Development Status of OPKO
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of OPKO
-
Figure Sales and Growth Rate Analysis of OPKO
-
Figure Revenue and Market Share Analysis of OPKO
-
Table Product and Service Introduction of OPKO
-
Table Company Profile and Development Status of Genomic Health
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genomic Health
-
Figure Sales and Growth Rate Analysis of Genomic Health
-
Figure Revenue and Market Share Analysis of Genomic Health
-
Table Product and Service Introduction of Genomic Health
-
Table Company Profile and Development Status of Roche
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche
-
Figure Sales and Growth Rate Analysis of Roche
-
Figure Revenue and Market Share Analysis of Roche
-
Table Product and Service Introduction of Roche
-
Table Company Profile and Development Status of Ambry Genetics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ambry Genetics
-
Figure Sales and Growth Rate Analysis of Ambry Genetics
-
Figure Revenue and Market Share Analysis of Ambry Genetics
-
Table Product and Service Introduction of Ambry Genetics
-
Table Company Profile and Development Status of Abbott
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott
-
Figure Sales and Growth Rate Analysis of Abbott
-
Figure Revenue and Market Share Analysis of Abbott
-
Table Product and Service Introduction of Abbott
-
Table Company Profile and Development Status of Myriad Genetics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Myriad Genetics
-
Figure Sales and Growth Rate Analysis of Myriad Genetics
-
Figure Revenue and Market Share Analysis of Myriad Genetics
-
Table Product and Service Introduction of Myriad Genetics
-
Table Company Profile and Development Status of Beckman Coulter
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Beckman Coulter
-
Figure Sales and Growth Rate Analysis of Beckman Coulter
-
Figure Revenue and Market Share Analysis of Beckman Coulter
-
Table Product and Service Introduction of Beckman Coulter
-
Table Company Profile and Development Status of DiaSorin
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of DiaSorin
-
Figure Sales and Growth Rate Analysis of DiaSorin
-
Figure Revenue and Market Share Analysis of DiaSorin
-
Table Product and Service Introduction of DiaSorin
-
